Terns Pharmaceuticals Statistics
Total Valuation
TERN has a market cap or net worth of $6.09 billion. The enterprise value is $5.07 billion.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TERN has 115.41 million shares outstanding. The number of shares has increased by 17.18% in one year.
| Current Share Class | 115.41M |
| Shares Outstanding | 115.41M |
| Shares Change (YoY) | +17.18% |
| Shares Change (QoQ) | +6.77% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | 105.42% |
| Float | 115.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.89 |
| P/TBV Ratio | 6.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 62.41, with a Debt / Equity ratio of 0.00.
| Current Ratio | 62.41 |
| Quick Ratio | 62.09 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -14.23% and return on invested capital (ROIC) is -10.16%.
| Return on Equity (ROE) | -14.23% |
| Return on Assets (ROA) | -9.91% |
| Return on Invested Capital (ROIC) | -10.16% |
| Return on Capital Employed (ROCE) | -10.92% |
| Weighted Average Cost of Capital (WACC) | 2.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.63M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TERN has paid $581,000 in taxes.
| Income Tax | 581,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,812.68% in the last 52 weeks. The beta is -0.41, so TERN's price volatility has been lower than the market average.
| Beta (5Y) | -0.41 |
| 52-Week Price Change | +1,812.68% |
| 50-Day Moving Average | 42.23 |
| 200-Day Moving Average | 22.42 |
| Relative Strength Index (RSI) | 75.64 |
| Average Volume (20 Days) | 8,717,211 |
Short Selling Information
The latest short interest is 18.19 million, so 15.76% of the outstanding shares have been sold short.
| Short Interest | 18.19M |
| Short Previous Month | 16.62M |
| Short % of Shares Out | 15.76% |
| Short % of Float | 15.81% |
| Short Ratio (days to cover) | 9.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -110.12M |
| Pretax Income | -95.63M |
| Net Income | -96.21M |
| EBITDA | -110.03M |
| EBIT | -110.12M |
| Earnings Per Share (EPS) | -$1.03 |
Full Income Statement Balance Sheet
The company has $1.02 billion in cash and $919,000 in debt, with a net cash position of $1.02 billion or $8.82 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 919,000 |
| Net Cash | 1.02B |
| Net Cash Per Share | $8.82 |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 8.96 |
| Working Capital | 1.01B |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -82.18M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 90,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -82.18M |
| FCF Per Share | -$0.71 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TERN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.18% |
| Shareholder Yield | -17.18% |
| Earnings Yield | -1.58% |
| FCF Yield | -1.35% |
Analyst Forecast
The average price target for TERN is $46.72, which is -11.50% lower than the current price. The consensus rating is "Buy".
| Price Target | $46.72 |
| Price Target Difference | -11.50% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -9.34% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |